Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angus G Dalgleish

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Vaccine|September 22, 2011
Therapeutic cancer vaccines: why so few randomised phase III studies reflect the initial optimism of phase II studiesAngus G Dalgleish
Expert Review of Vaccines|December 21, 2004
Cancer vaccines as a therapeutic strategyAngus G Dalgleish
Expert Review of Vaccines|February 3, 2006
Immunotherapy and the development of cancer vaccinesAngus G Dalgleish
Immunotherapy|March 26, 2015
Rationale for combining immunotherapy with chemotherapyAngus G Dalgleish
Expert Review of Anticancer Therapy|November 26, 2019
Why do the majority of patients not respond at all, or only partially or transiently, to immunotherapy?Angus G Dalgleish
Cancer Immunology, Immunotherapy : CII|March 4, 2018
The Third Institute for Cancer Vaccines and Immunotherapy (ICVI) symposium on immunotherapy: May 12-13, 2017, Royal Society, London, UKAngus G Dalgleish
Human Vaccines & Immunotherapeutics|January 28, 2015
Vaccines versus immunotherapy: overview of approaches in deciding between optionsAngus G Dalgleish
Cancer Treatment and Research|April 14, 2006
Inflammation and cancer: the role of the immune response and angiogenesisAngus G Dalgleish, Ken O'Byrne
Clinical Medicine (London, England)|July 16, 2008
Pathogenesis of HIV: non-specific immune hyperactivity and its implications for vaccinesMartin Cadogan, Angus G Dalgleish
Cancer Informatics|March 18, 2010
The power of the web in cancer drug discovery and clinical trial design: research without a laboratory?Christine Galustian, Angus G Dalgleish
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Vaccine|September 22, 2011
Therapeutic cancer vaccines: why so few randomised phase III studies reflect the initial optimism of phase II studiesAngus G Dalgleish
Expert Review of Vaccines|December 21, 2004
Cancer vaccines as a therapeutic strategyAngus G Dalgleish
Expert Review of Vaccines|February 3, 2006
Immunotherapy and the development of cancer vaccinesAngus G Dalgleish
Immunotherapy|March 26, 2015
Rationale for combining immunotherapy with chemotherapyAngus G Dalgleish
Expert Review of Anticancer Therapy|November 26, 2019
Why do the majority of patients not respond at all, or only partially or transiently, to immunotherapy?Angus G Dalgleish
Cancer Immunology, Immunotherapy : CII|March 4, 2018
The Third Institute for Cancer Vaccines and Immunotherapy (ICVI) symposium on immunotherapy: May 12-13, 2017, Royal Society, London, UKAngus G Dalgleish
Human Vaccines & Immunotherapeutics|January 28, 2015
Vaccines versus immunotherapy: overview of approaches in deciding between optionsAngus G Dalgleish
Cancer Treatment and Research|April 14, 2006
Inflammation and cancer: the role of the immune response and angiogenesisAngus G Dalgleish, Ken O'Byrne
Clinical Medicine (London, England)|July 16, 2008
Pathogenesis of HIV: non-specific immune hyperactivity and its implications for vaccinesMartin Cadogan, Angus G Dalgleish
Cancer Informatics|March 18, 2010
The power of the web in cancer drug discovery and clinical trial design: research without a laboratory?Christine Galustian, Angus G Dalgleish
Pageof 9